Ovarian Leydig Cell Tumor and Postmenopausal Hirsutism with Signs of Virilization

    March 2021 in “ Case Reports
    Catia Ferrinho, Eugénia Silva, Manuela Oliveira, João Sequeira Duarte
    Image of study
    TLDR A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.
    A 71-year-old woman with a 10-year history of postmenopausal hirsutism and virilization underwent a total hysterectomy and bilateral oophorectomy after elevated androgen levels and postmenopausal vaginal bleeding suggested an ovarian source of hyperandrogenism. The surgery revealed a Leydig cell tumor in the left ovary and endometrial carcinoma. Her hirsutism improved within a month post-surgery, and she was referred for further oncological treatment. The case underscores the need for thorough evaluation of virilization in postmenopausal women, as it can indicate life-threatening tumors and have serious health implications. Leydig cell tumors are rare and usually benign, but the long-term effects of increased androgen levels in postmenopausal women are not well understood.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 24 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

      community Any balding females? I need advice with coping :(

       16 upvotes 8 years ago
      A 27-year-old woman is struggling with hair loss, feeling self-conscious and seeking advice on coping. She mentions trying Minoxidil but is hesitant due to scalp issues and is looking for ways to regain confidence.

    Similar Research

    5 / 1000+ results